Top Markets
Coin of the day
Sinphar Pharmaceutical Co. Ltd. Sinphar Pharmaceutical Co. Ltd.

Sinphar Pharmaceutical Co. Ltd.

1734
Rang in Aktien #18495
Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the... Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally. It operates through three segments: Pharmaceuticals, Healthy Food, and Others. The company offers pharmaceutical products, including antineoplastic, ophthalmic, ENT, oral, respiratory system, dermatology, analgesic and NSAIDs, metabolic and nutrient, gastrointestinal, and other products; and healthy food under the Sinphar, DailyCare, Migus, YouBest, and SynCoreBio brands. It also provides moisturizer repair essence, anti aging cream, renewable oi, and UV defence cream under the DYNASKIN brand; serum, revitalizing cream, hygiene, sunblock, sunscreen, and lightening tables under the Yestuner brand; and shower gel and hair shampoo. In addition, the company is involved in the provision of testing and development, as well as product design and manufacturing services. The company was incorporated in 1977 and is based in Yilan City, Taiwan.
Aktienkurs
$0.97305026
Marktkapitalisierung
$196.18M
Veränderung (1 Tag)
-0.16%
Veränderung (1 Jahr)
0.50%
Land
TW
Handel Sinphar Pharmaceutical Co. Ltd. (1734)

Kategorie

P/B-Verhältnis für Sinphar Pharmaceutical Co. Ltd. (1734)
P/B-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von Sinphar Pharmaceutical Co. Ltd. beträgt das aktuelle Kurs-Buchwert-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/B-Verhältnis bei 0.
P/B-Verlauf für Sinphar Pharmaceutical Co. Ltd. von 2026 bis 2026
P/B-Verhältnis zum Jahresende
Jahr P/B-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/B-Verhältnis für ähnliche Unternehmen oder Wettbewerber